/
BCTXZ
$0.12+$0.01 (+6.80%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.06 – $0.52
14% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
WARRANT
Change$-1.20
BriaCell Therapeutics Corp. Warrant
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
www.briacell.com- Employees
- 4
- IPO / List date
- Apr 25, 2025
- HQ
- WEST VANCOUVER, A1
Held by traders on TradeandTell
No one on the platform currently holds BCTXZ.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BCTXZ as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BCTXZ yet.